Transanal Total Mesorectal Excision (taTME), also known as ‘bottom-up' surgery, is a new minimally invasive robotic alternative to conventional surgery for patients with lower rectal cancer. The main ...
The 3-year local recurrence rate was 3.6% for transanal TME and 4.4% for laparoscopic TME. The 3-year overall survival was 92 ...
A "watch and wait" strategy after total neoadjuvant therapy showed similar outcomes and safety to total mesorectal in stage ...
Tumour-free ctDNA detection as a decision tool to support organ preservation in node-negative rectal cancer undergoing neoadjuvant chemotherapy, excision, and observation in the phase II NEO trial ...
Magnetic resonance imaging (MRI) can spare many patients with rectal cancer from invasive surgery that can ... require what ...
From colorectal cancer to inflammatory bowel disease to benign ... including transanal endoscopic microsurgery (TEM), transanal minimally invasive surgery (TAMIS), transanal Total Mesorectal Excision ...
colorectal cancer; ECM, extracellular matrix; MDSCs, myeloid-derived suppressor cells; TAMs, tumor-associated macrophages; TME, tumor microenvironment; Tregs, regulatory T cells. Strategies to Boost ...
News Medical on MSN10d
Tracking cfDNA levels may help better evaluate surgery colorectal cancer effectivenessA new research paper was published in Oncotarget's Volume 16 on January 21, 2025, titled "Assessment of cfDNA release dynamics during colorectal cancer surgery." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback